Social and Clinical Aspects of Pelvic Pain in Turkey

• ClinicalTrials.gov Identifier: NCT06038773
• Recruitment Status: Completed
• First Posted: September 15, 2023
• Last Update Posted: September 15, 2023
• Sponsor: Yeditepe University
• Information provided by (Responsible Party): Yeditepe University

Study Description

Brief Summary:

Chronic Pelvic Pain (CPP) is a common medical condition with a complex treatment due to different variables that influence its clinical course.There is a growing literature which discussing the effect of ethnicity and culture on pain. It was aimed to invesitigate whether there is a considerable difference in the presentation and experience of pelvic pain in women from a different societies and cultures.

Condition or disease	Intervention/treatment
Chronic Pelvic Pain Syndrome	Diagnostic Test: Diagnosis

Detailed Description:

Chronic Pelvic Pain (CPP) is a common medical condition with a complex treatment due to different variables that influence its clinical course.There is a growing literature which discussing the effect of ethnicity and culture on pain. It was aimed to invesitigate whether there is a considerable difference in the presentation and experience of pelvic pain in women from a different societies and cultures.

The study includes randomly selected 45 females who completed a comprehensive set of questions derived from International Pelvic Pain Society (IPPS), pelvic pain assesment form. Character and intensity of pain, sexual abuse and harresment, coping with pain, physical activites (exercising) and comorbidities were evaluated. The McGill pain questionnaire short form was used to evaluate pain. Sexual Abuse Items in the Questionnaire (modified) to assess patients' sexual abuse status.

Study Design

• Study Type: Observational
• Actual Enrollment: 45 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Social and Clinical Aspects of Pelvic Pain in Turkey
• Actual Study Start Date: June 10, 2023
• Actual Primary Completion Date: June 30, 2023
• Actual Study Completion Date: July 22, 2023

Groups and Cohorts

Intervention Details:

• Diagnostic Test: Diagnosis
  Baseline data were presented with descriptive statistics. Sociodemographic information, pregnancy status, surgical history, exercise habits, gynecologic, obstetric, urologic and gastrointestinal history of the patients were evaluated with the "Patient Information Form".Pain intensity was evaluated with the McGill pain questionnaire short form. At the same time, the patients drew the areas where they felt the most pain with the pain maps scale. Pain intensity during sexual intercourse was evaluated with the Visual Analog Scale (VAS).Sexual Abuse Items on the Questionnaire (Modified from Badgley).

Outcome Measures

Primary Outcome Measures :

1. McGill pain scale [ Time Frame: 1 month ]
   ".Pain intensity was evaluated with the McGill pain questionnaire short form. At the same time, the patients drew the areas where they felt the most pain with the pain maps scale.

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult)
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes
• Sampling Method: Non-Probability Sample

Study Population

The study included 45 women with pelvic pain. Women aged 18-65 years with pelvic pain ≥6 months were eligible. The study was conducted at Yeditepe University Hospital on female patients diagnosed with chronic pelvic pain syndrome due to pelvic floor muscle problems by a gynecologist.

Criteria

Inclusion Criteria:

• Women aged 18-65 years with pelvic pain ≥6 months were eligible.

Exclusion Criteria:

• Patient who have had pelvic surgery
• Gynecological female patients with problems other than pelvic pain

Contacts and Locations

Locations

Turkey

Nilüfer Cerbezer

İstanbul, Turkey, 34758

Sponsors and Collaborators

Yeditepe University

Investigators

• Principal Investigator: nilüfer cerbezer, Msc; Yeditepe Üniversitesi

More Information

• Responsible Party: Yeditepe University
• ClinicalTrials.gov Identifier: NCT06038773
• Other Study ID Numbers: Yeditepeu3
• First Posted: September 15, 2023
• Last Update Posted: September 15, 2023
• Last Verified: September 2023

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Undecided

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Pelvic Pain; Pain; Neurologic Manifestations